Codexis makes engineered enzymes and manufacturing services that help pharmaceutical companies produce drug therapeutics. It last closed at $1.07 on Nov 17, up 2.39% on the day. CDXS last reported earnings on Tue, Aug 11, 2026.
Only 1 firm rated CDXS in the past 90 days, not enough for a consensus
Average 12-month target
$5.00
▲ 367.3% upside
Based on 1 analyst who set a price target on CDXS in the past 90 days. The average target is $5.00, with a high of $5.00 and a low of $5.00, compared with the last close of $1.07.
Low $5.00Avg $5.00High $5.00
Blue marker: last close $1.07
Highest target$5.00
Average target$5.00
Lowest target$5.00
Latest rating changes
Stephens & Co.Reiterated
Nov 16Buy$5
Piper SandlerMaintained
Aug 17Buy$8
Date
Firm
Action
Rating
Price target
Nov 16
Stephens & Co.
Reiterated
Buy
$5
Aug 17
Piper Sandler
Maintained
Buy
$8
Loading…
Technical Analysis
CDXS · as of the Nov 17 close · updated after every close
Downtrend
The stock is 6% below its 20 day and 19% below its 50 day average. It is 67% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 44). The nearest support is the Pivot S1 at $1.04, and the nearest resistance the Pivot at $1.08.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 9.1%/day
Key levels
$2.9852 week high+178.5%
$1.79200 day average+67.3%
$1.55100 day average+44.9%
$1.2750 day average+18.7%
$1.17Swing high (Nov 9)+9.3%
$1.1420 day average+6.5%
$1.11Pivot R1+3.7%
$1.08Pivot+0.9%
$1.07Last close
$1.04Pivot S1−2.8%
$0.99Swing low (Nov 5)−7.5%
$0.9052 week low−15.9%
Indicators
RSI (14)
43.64
Middle of its range
Neutral
MACD
-0.08
Below its signal line
Bearish
Stochastic
44.0
Middle of its range
Neutral
ADX (14)
36.4
Trending down
Williams %R
-57.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-45.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.9%
Change over 10 sessions
Bearish
ATR (14)
$0.10
Typical daily range, 9.1% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 22.8%/day
Key levels
$2.9852 week high+178.5%
$1.79200 day average+67.3%
$1.55100 day average+44.9%
$1.2750 day average+18.7%
$1.17Swing high (Nov 9)+9.3%
$1.1420 day average+6.5%
$1.11Pivot R1+3.7%
$1.08Pivot+0.9%
$1.07Last close
$1.04Pivot S1−2.8%
$0.99Swing low (Nov 5)−7.5%
$0.9052 week low−15.9%
Indicators
RSI (14)
33.40
Weak, oversold below 30
Neutral
MACD
-0.24
Below its signal line
Bearish
Stochastic
20.1
Middle of its range
Neutral
ADX (14)
24.4
Weak trend
Williams %R
-80.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−27.2%
Change over 10 sessions
Bearish
ATR (14)
$0.24
Typical daily range, 22.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CDXS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CDXS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CDXS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CDXS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDXS is in one of them and how their past CDXS trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Codexis
Codexis develops engineered enzymes and other proteins that improve how drugs are made, using its CodeEvolver platform. Its ECO Synthesis platform uses enzymes to manufacture RNA interference therapeutics, and it offers method development, process development and manufacturing support to drug developers. Its small molecule business sells optimized enzymes to large pharmaceutical companies to raise yields and purity. The company is based in Redwood City, California.